Raily Aesthetic Medicine International Holdings (HKSE:02135) Total Equity: HK$108.5 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02135 Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
47 GF Score
Price HK$0.12
GF Value HK$0.14
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Raily Aesthetic Medicine International Holdings Total Equity?

Raily Aesthetic Medicine International Holdings HKSE:02135 +2.59% 47 Total Equity is HK$108.5 Mil as of Dec. 2025. GuruFocus rates HKSE:02135 with a GF Score™ of 47/100 and a GF Value™ of HK$0.14 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Raily Aesthetic Medicine International Holdings's total equity for the quarter that ended in Dec. 2025 was HK$108.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Raily Aesthetic Medicine International Holdings Total Equity Historical Data

* Premium members only.

The historical data trend for Raily Aesthetic Medicine International Holdings's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raily Aesthetic Medicine International Holdings Total Equity Chart

Raily Aesthetic Medicine International Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only 223.29 185.24 145.02 101.98 108.55

Raily Aesthetic Medicine International Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.02 162.07 101.98 96.54 108.55
HKSE:02135
47GF Score
Raily Aesthetic Medicine International Holdings Ltd HKSE:02135
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raily Aesthetic Medicine International Holdings Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Raily Aesthetic Medicine International Holdings's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=262.539-153.991
=108.5

Raily Aesthetic Medicine International Holdings's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=262.539-153.991
=108.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$108.5 Mil mean?
Raily Aesthetic Medicine International Holdings (HKSE:02135) has a Total Equity of HK$108.5 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Raily Aesthetic Medicine International Holdings and its competitors.
Is Raily Aesthetic Medicine International Holdings' Total Equity too high?
Raily Aesthetic Medicine International Holdings' current Total Equity is HK$108.5 Mil. Overall, Raily Aesthetic Medicine International Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raily Aesthetic Medicine International Holdings' Total Equity compare to HCA and THC?
Raily Aesthetic Medicine International Holdings' Total Equity of HK$108.5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Raily Aesthetic Medicine International Holdings and its competitors. Raily Aesthetic Medicine International Holdings's current Total Equity is HK$108.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raily Aesthetic Medicine International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings (HKSE:02135) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.12 — trading 15% below its estimated fair value. The current Total Equity is HK$108.5 Mil. Raily Aesthetic Medicine International Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Raily Aesthetic Medicine International Holdings (HKSE:02135), the current Total Equity is HK$108.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?

Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued. The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14. GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:02135:

  • Total Equity: HK$108.5 Mil
  • GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raily Aesthetic Medicine International Holdings Business Description

Address No. 290 North Zhongshan Road, 3-5th Floor, Minhang Tower, Gongshu District, Hangzhou, CHN
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score

Get the complete analysis for HKSE:02135

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.12
Price
HK$0.14
GF Value